Article metrics

Download PDFPDF

256 Single-agent zalifrelimab (anti-CTLA-4) shows clinical benefit in rare tumors – case report from phase 2 study (NCT03104699)

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020212011
Dec 202066027
Jan 20216405
Feb 20214803
Mar 20214404
Apr 20214003
May 2021405
Jun 2021002
Jul 2021005
Aug 2021002
Sep 2021003
Oct 202134024
Nov 202130016
Dec 20211602
Jan 20222801
Feb 20221404
Mar 20221205
Apr 20223603
May 20223801
Jun 20221601
Jul 20221800
Aug 20223004
Sep 20222403
Oct 20221802
Nov 20222204
Dec 20223203
Jan 20231800
Feb 20232600
Mar 20232400
Apr 20232209
May 20232600
Jun 20232203
Jul 20233401
Aug 20233805
Sep 20231801
Oct 20234204
Nov 20235005
Dec 20233400
Jan 20242800
Feb 20243001
Mar 20243402
Apr 20242801
May 20246202
Jun 20244400
Jul 20242001
Aug 20243601
Sep 20242201
Oct 20242003
Nov 20242203
Dec 202444012
Jan 20252405
Feb 20251606
Mar 2025001
Apr 2025005
May 2025003
Jun 2025004
Total16300222